AI Can Help Health Care Providers Make Diagnostic and Therapeutic Decisions - SPONSOR CONTENT FROM SIEMENS HEALTHINEERS


Among health care systems and payers--both government and private--this term implies unnecessary risk to patients, diminished quality of care, and increased health care costs. From the numerous studies and papers published on the topic, a common description emerges: unwarranted variations are not directly due to the inherent variations of a given patient; rather to the variations in the processes and conditions of how care is delivered, especially when it results in inconsistencies in the adherence to and administering of evidence-based guidelines of care. Consider the variations that exist among complex disease pathways such as oncology. In lung cancer, over 75% of patients are at an advanced state of disease when diagnosed, making it the leading cause of cancer deaths among both men and women. Thus, early detection, either as a focused diagnosis or an incidental finding, is key for an optimal five-year survival rate, as is the rapid commencement of a treatment protocol. At the other end of the spectrum is prostate cancer.